BALYASNY ASSET MANAGEMENT L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q1 2023$6,435
+86.5%
75,0000.0%0.00%
Q4 2022$3,450
-68.6%
75,0000.0%0.00%
Q3 2022$11,000
+37.5%
75,0000.0%0.00%
Q2 2022$8,000
-52.9%
75,0000.0%0.00%
Q1 2022$17,00075,0000.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 369,289$3,774,1340.21%
Radcliffe Capital Management, L.P. 200,049$2,052,5030.06%
LMR Partners LLP 125,000$1,277,5000.02%
Q Global Advisors, LLC 195,489$200.01%
MARSHALL WACE, LLP 190,150$1,954,7430.00%
MMCAP International Inc. SPC 325,000$32,4680.00%
PERISCOPE CAPITAL INC. 867,072$37,1400.00%
COWEN AND COMPANY, LLC 177,845$17,7660.00%
CANTOR FITZGERALD, L. P. 250,000$250.00%
EHP Funds Inc. 125,186$60.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders